Promega™ ApoLive-Glo™ Multiplex Assay
Measures both the number of viable cells as a marker of cytotoxicity and caspase activation as a marker of apoptosis in a single well to determine the mechanism of cell death
Manufacturer: promega™ G6411
U.S. Patents 7,416,854; 7,553,632 and other patents pending.
U.S. Patents 6,602,677 and 7,241,584, Australian Patents 754312 and 785294 and other patents and patents pending.
U.S. Patents 7,148,030 and 7,384,758, Australian Patent 2003216139 and other patents pending.
The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024, 5,674,713 and 5,700,673.
|Kit Contents||1 x 50μL GF-AFC substrate, 2 x 10mL Assay Buffer, 5 x 10mL Caspase-Glo™ 3/7 Buffer, 5 x 1 bottle Caspase-Glo™ 3/7 substrate|
|Detection Method||Fluorescence, Luminescence|
|For Use With (Application)||Determine mechanism of cell death, Profile compounds for cytotoxic risk|
|Quantity||5 x 10mL|